Page 98

Abril_2107

artículo de revisión Referencias Dieta mediterránea y enfermedad de Alzheimer - A. Miranda et al 1. Alzheimer's Association. 2014 Alzheimer's disease facts and figures. Alzheimers Dement 2014; 10 (2): e47-e92. 2. Gajardo J, Monsalves M. Demencia, un tema urgente para Chile. Rev Chil Salud Pública 2013; 17 (1): 22-5. 3. Bherer L, Erickson KI, Liu-Ambrose T. A Review of the Effects of Physical Activity and Exercise on Cognitive and Brain Functions in Older Adults. J Aging Res 2013; 2013: 657508. 4. Maccioni CB, Arzola ME, Mujica L, Maccioni R. Nuevos paradigmas en el estudio de la patogénesis de la enfermedad 506 de Alzheimer. Rev Chil Neuro-Psiquiat 2003; 41: 33-46. 5. Custodio N, Herrera E, Lira D, Montesinos R, Linares J, Bendezú L. Deterioro cognitivo leve: ¿dónde termina el envejecimiento normal y empieza la demencia? Anales de la Facultad de Medicina 2012; 73: 321-30. 6. Duyckaerts C, Delatour BT, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol 2009; 118 (1): 5-36. 7. García S, Coral VRM, Meza DE, Lucino CJ, Martínez SB, Villagómez OAJ. Enfermedad de Alzheimer: una panorámica desde su primera descripción hacia una perspectiva molecular. Med Int Mex 2009; 25 (4): 300- 12. 8. Jakob-Roetne R, Jacobsen H. Alzheimer's Disease: From Pathology to Therapeutic Approaches. Angew Chem Int Ed Engl 2009; 48 (17): 3030-59. 9. Leslie Crews EM. Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet 2010; 19 (1): R12-R20. 10. Palop JJ, Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci 2010; 13 (7): 812-8. 11. Karran E, Mercken M, Strooper BD. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 2011; 10 (9): 698-712. 12. Ittner LM, Götz J. Amyloid-b and tau-a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 2011; 12 (2): 67-72. 13. Barage SH, Sonawane KD. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease. Neuropeptides 2015; 52: 1-18. 14. O taegui-Arrazola A, Amiano P, Elbusto A, Urdaneta E, Martínez-Lage P. Diet, cognition, and Alzheimer's disease: food for thought. Eur J Nutr 2014; 53 (1): 1-23. 15. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011; 7 (3): 137-52. 16. Vagelatos NT, Eslick GD. Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship. Epidemiologic Reviews 2013. 17. Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ. An update on type 2 diabetes, vascular dementia and Alzheimer's disease. Exp Gerontol 2012; 47 (11): 858-64. 18. Moreira PI. High-sugar diets, type 2 diabetes and Alzheimer's disease. Curr Opin Clin Nutr Metab Care 2013; 16 (4): 440-5. 19. B aram M, Atsmon-Raz Y, Ma B, Nussinov R, Miller Y. Amylin-Ab oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease. Phys Chem Chem Phys 2015; 18: 2330-8. 20. Profenno LA, Porsteinsson AP, Faraone SV. Meta Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders. Biol Psychiatry 2010; 67 (6): 505-12. 21. Ferreira ST, Clarke JR, Bomfim TR, De Felice FG. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease. Alzheimers Dement 2014; 10 (1): S76-S83. 22. Arnoldussen IAC, Kiliaan AJ, Gustafson DR. Obesity and dementia: Adipokines interact with the brain. Eur Neuropsychopharmacol 2014; 24 (12): 1982-99. 23. Misiak B, Leszek J, Kiejna A. Metabolic syndrome, mild cognitive impairment and Alzheimer's disease-The emerging role of systemic low-grade inflammation and adiposity. Brain Res Bull 2012; 89 (3-4): 144-9. 24. Platt TL, Beckett TL, Kohler K, Niedowicz DM, Murphy MP. Obesity, diabetes, and leptin resistance promote tau pathology in a mouse model of disease. Neuroscience 2016; 315: 162-74. 25. Campdelacreu J. Enfermedad de Parkinson y enfermedad de Alzheimer: factores de riesgo ambientales. Neurología 2014; 29 (9): 541-9. 26. Kalaria RN. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev 2010; 68 (suppl 2): S74-S87. 27. Keys A, Menotti A, Karvonem M, Aravanis C, Blackburn H, Buzina R, et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986; 124 (6): 903-15. 28. Feart C, Samieri C, Barberger-Gateau P. Mediterranean diet and cognitive health: an update of available knowledge. Curr Opin Clin Nutr Metab Care 2015; 18 (1): 51-62. 29. Scarmeas N, Stern Y, Tang M-X, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006; 59 (6): 912-21. Rev Med Chile 2017; 145: 501-507


Abril_2107
To see the actual publication please follow the link above